financetom
Business
financetom
/
Business
/
Factbox-Biggest deals for global sports teams
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Factbox-Biggest deals for global sports teams
Jun 19, 2025 3:32 PM

(Reuters) -The Buss family agreed in principle on Friday to sell the Los Angeles Lakers, who have won 17 National Basketball Association championships, to financier Mark Walter in a world record deal that values the franchise at $10 billion.

Walter is chief executive officer of Guggenheim Partners, a global financial services firm with more than $325 billion in assets.

He led the group that bought the Los Angeles Dodgers in 2012, according to The Athletic, and currently holds the controlling share in the baseball franchise.

Here are the biggest purchases of global sports teams in history:

1. Los Angeles Lakers (NBA): Majority stake sold to MarkWalter, valuing franchise at about $10 billion (June 2025) 2. Boston Celtics (NBA): Sold to  private equity investorBill Chisholm for $6.1 billion (March 2025) 3. Washington Commanders (NFL): Sold to a group led by JoshHarris for $6.05 billion. Harris is co-founder of private equityfirm Apollo Global Management (July 2023) 4. Chelsea Football Club : Sold to aninvestment group led by Todd Boehly and Clearlake Capital for$5.3 billion (May 2022) 5. Denver Broncos (NFL): Sold to Walmart heir Rob Walton for$4.65 billion (August 2022) 6. Phoenix Suns and Phoenix Mercury (NBA, WNBA): Sold tobillionaire mortgage lender Matt Ishbia (December 2022) 7. Milwaukee Bucks (NBA): Sold to Cleveland Browns ownerJimmy and Dee Haslam for $3.5 billion (April 2023) 8. Brooklyn Nets (NBA): Sold to Chinese billionaire Joe Tsaifor $3.3 billion (September 2019) 9. New York Mets (MLB): Sold to investor Steve Cohen for$2.4 billion (November 2020) 10. Minnesota Timberwolves (NBA): Sold to investor group ledby Mark Lore and Alex Rodriguez for $1.5 billion (April 2025)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Market Chatter: Ram Trucks to Launch 10-Year, 100,000-Mile Warranty Across 2026 Lineup
Market Chatter: Ram Trucks to Launch 10-Year, 100,000-Mile Warranty Across 2026 Lineup
Jun 18, 2025
07:48 AM EDT, 06/18/2025 (MT Newswires) -- Stellantis' ( STLA ) Ram Trucks plans to launch a 10-year or 100,000-mile warranty for its 2026 vehicle lineup, marking a key element of its 18-month turnaround strategy, CNBC reported Wednesday, citing Ram CEO Tim Kuniskis. The new warranty will cover major components, including the engine, transmission, transfer case, driveshafts, differentials, and axles....
Somnigroup Reprices $1.6 Billion Term Loan
Somnigroup Reprices $1.6 Billion Term Loan
Jun 18, 2025
07:48 AM EDT, 06/18/2025 (MT Newswires) -- Somnigroup International ( SGI ) said Wednesday that it has repriced its $1.6 billion term loan B due October 2031. The loan was repriced to lower the current applicable margin by 25 basis points from SOFR plus 2.50% to SOFR plus 2.25%. The company also plans to prepay $100 million of the outstanding...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Merck Doses First Patient in Phase 3 Trial of Prostate Cancer Drug Candidate
Merck Doses First Patient in Phase 3 Trial of Prostate Cancer Drug Candidate
Jun 18, 2025
07:54 AM EDT, 06/18/2025 (MT Newswires) -- Merck ( MRK ) said Wednesday it has dosed the first patient in a phase 3 trial of ifinatamab deruxtecan in participants with pretreated metastatic castration-resistant prostate cancer. The IDeate-Prostate01 phase 3 study is evaluating the efficacy and safety of the investigational drug against docetaxel. Ifinatamab deruxtecan is an antibody-drug conjugate, which is...
Copyright 2023-2026 - www.financetom.com All Rights Reserved